Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Changes in Radial Artery During VATS
NCT03302221Phase 4Withdrawn
- Sponsor
- China Medical University
- Start
- Oct 2017
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in lung cancer (3 arms), sponsored by China Medical University. Primary endpoint: The Change of end-diastolic velocity. Planned start Oct 2017; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT03302221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302221.